Pituitary Neuroendocrine Tumor: Is It Benign or Malignant?-Reference-Cited by-同舟云学术

Pituitary Neuroendocrine Tumor: Is It Benign or Malignant?

Published:2023 Issue:3 Volume:11 Page:173
ISSN:2288-2405
Container-title:Brain Tumor Research and Treatment
language:en
Short-container-title:Brain Tumor Res Treat

Author:

Lee Chae Heuck¹^ORCID

Affiliation:

1. Department of Neurosurgery, Ilsan Paik Hospital, College of Medicine, Inje University, Goyang, Korea.

Publisher

XMLink

Subject

General Earth and Planetary Sciences,General Engineering,General Environmental Science

Link

https://btrt.org/pdf/10.14791/btrt.2023.0015

Reference14 articles.

1. WHO Classification of Tumours Editorial Board. Central nervous system tumours: WHO classification of tumours. Volume 6 [Internet]. 5th ed. Lyon. International Agency for Research on Cancer. 2021. Accessed Nov 1, 2022. at https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Central-Nervous-System-Tumours-2021

2. WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours: WHO classification of tumours series. Volume 10 [Internet]. 5th ed. Lyon. International Agency for Research on Cancer. 2022. Accessed Nov 1, 2022. at https://tumourclassification.iarc.who.int/

3. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018

4. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

5. Overview of the 2022 WHO Classification of Pituitary Tumors

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical approaches to diagnosing PitNETs/adenomas based on cell lineage;Brain Pathology;2024-08-25

2. Predictors of morphofunctional features of somatotrophic tumors and of the effectiveness of treatment with first-generation somatostatin receptor ligands;Meditsinskiy sovet = Medical Council;2024-05-19

3. Unification of pathomorphological examination of patients with neuroendocrine tumors of the pituitary gland. Controversial issues of the new classification;Problems of Endocrinology;2023-11-14